FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

2',3'-Dideoxyinosine & sCD4(soluble recombinant protein)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 11 USDMF, 2 CEP/COS, 1 EU WC, 2 NDC API, 5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers, 29 FDA Orange Book, 25 Europe, 18 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML, CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Evonik, 1 Rochem International Inc, 1 SPI Pharma, 12 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 13 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives, 31 Controlled & Modified Release, 29 Thickeners and Stabilizers, 24 Disintegrants & Superdisintegrants, 24 Fillers, Diluents & Binders, 14 Granulation, 14 Solubilizers, 13 Film Formers & Plasticizers, 12 Topical, 12 Taste Masking, 11 Direct Compression, 9 Rheology Modifiers, 9 Empty Capsules, 7 Lubricants & Glidants, 7 Co-Processed Excipients, 5 Coloring Agents, 4 Emulsifying Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 1 Parenteral

GLOBAL SALES INFORMATION

8 Regulatory FDF Prices

8 Regulatory FDF Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 4 Others

Xls download

Filters

List of Suppliers

Reset Filter

Price Info

Product Main Page

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/01/2026	Ajinomoto Company	Japan	AJINOMOTO CO INC	7694	2'3'-DIDEOXYINOSINE	1988-09-30	Inactive	II	N/A
29/01/2026	Aurisco Pharmaceutical	China	AURISCO PHARMACEUTICAL LTD	23635	DIDANOSINE	2010-04-16	Inactive	II	N/A

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

2',3'-Dideoxyinosine & SCD4(soluble Recombinant Protein)

2',3'-Dideoxyinosine & sCD4(soluble recombinant protein)

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

11 USDMF

2 CEP/COS

1 EU WC

2 NDC API

5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers

29 FDA Orange Book

25 Europe

18 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Evonik

1 Rochem International Inc

1 SPI Pharma

12 DKSH

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

18 BASF

13 Corel Pharma Chem

4 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

8 Ideal Cures

2 Ingredion Pharma Solutions

10 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

6 Microlex e.U

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

12 Roquette

7 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

2 Valens Pharmachem

3 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives

31 Controlled & Modified Release

29 Thickeners and Stabilizers

24 Disintegrants & Superdisintegrants

24 Fillers, Diluents & Binders

14 Granulation

14 Solubilizers

13 Film Formers & Plasticizers

12 Topical

12 Taste Masking

11 Direct Compression

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons